BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 130496)

  • 1. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
    van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
    Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
    Wagener DJ; Geestman E; Borgonjen A; Haanen C
    Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte function in patients with Hodgkin's disease.
    Rühl H; Vogt W; Rühl U
    G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymphocyte response in Hodgkin's disease.
    Braeman J; Evans IH; Deeley TJ
    Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies of the proportions of T, B and O-lymphocytes and of the degree of blastic transformation following stimulation with PHA in patients with Hodgkin's disease].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Apr; 57(4):297-305. PubMed ID: 300871
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease.
    Begemann M; Claas G; Falke H
    Klin Wochenschr; 1982 Jan; 60(1):19-26. PubMed ID: 6210797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 12. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hypersensitivity and lymphocytic transformation in patients with Hodgkin's disease and granulomas.
    Pick AI; Duer D; Kessler H; Kenan Z; Weiss H; Topilski M
    Cancer; 1978 Jun; 41(6):2192-6. PubMed ID: 657087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
    Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
    J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte response to the phytomitogens in untreated and treated patients with Hodgkin's disease.
    Romagnani S; Amadori A; Biti G; Bellesi G; Ricci M
    Int Arch Allergy Appl Immunol; 1976; 51(3):378-89. PubMed ID: 1279027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.